The researchers will use genomics to address challenges facing Canada's forestry, healthcare, agricultural, and aquacultural industries.
Researchers reported on the impact sequencing projects have already had on participants, as well as the challenges, particularly in data interpretation and storage.
The recommendations resulted from two meetings that brought together physicians, lab workers, researchers, genetic counselors, and patient families from the US and Canada.
Researchers have found that mutations present in medulloblastoma tumors at relapse differ substantially from those present at diagnosis.
Removing exon duplications is just one way in which the genome editing technology could be applied to treat hereditary genetic diseases.
Researchers found that array-based testing and exome sequencing contributed uniquely to ASD diagnosis, and that the diagnostic yield of testing was higher in complex autism cases.
BioTeam has developed a web portal for the MSSNG repository that offers easy access to genomic, phenotype, and clinical data collected through the project.
David Glazer from Google Genomics provided an update on the MSSNG project, a collaboration between Autism Speaks, The Hospital for Sick Children in Toronto, and Google.
The group is currently comparing a lab-developed nCounter assay to "gold-standard" RT-PCR assays to retrospectively analyze sarcoma patient samples.
Researchers identified a form of ultra-hypermutated cancer that occurs in individuals with inherited and somatic mutations in their DNA repair machinery.
The Washington Post reports that a Russian Academy of Sciences commission has led to the retraction of hundreds of scientific papers.
The Los Angeles Times' Daily Pilot reports the chief executive of Vantari Genetics has pleaded guilty in a kickback scheme.
News 4 Jax reports that a Florida bill to prevent life and long-term care insurers from using genetic information in their coverage decisions has easily passed one committee.
In Science this week: potentially pathogenic mutations found in hematopoietic stem cells from young healthy donors, and more.